Forbes | Thought-To-Text Typing Hits 90 Characters/Minute With 94% Accuracy

Thought-To-Text Typing Hits 90 Characters/Minute With 94% Accuracy   New brain-computer interface technology is giving quadriplegic and tetraplegic patients the ability to control computers, thought type at 90 characters a minute, and move robotic arms to feed themselves, or high-five family members. Built by Blackrock Neurotech and including technology licensed from Stanford University, the technology is scheduled…

Read more

The Observer | Brain Implant Technology Lets Paralysis Patients Move, Touch and Feel With Their Thoughts

Brain Implant Technology Lets Paralysis Patients Move, Touch, and Feel With Their Thoughts “The BCI research community is extremely vibrant. They are looking at everything from [enabling people to] walk again, see again, hear again, and even feel again. Anything you can think of, they are researching it,” said Marcus Gerhardt, CEO of Blackrock Neurotech,…

Read more

Tech First | Thought to text: brain-computer interface lets you type, move robotic arms with your mind

Thought to text: brain-computer interface lets you type, move robotic arms with your mind   Thinking to type sounds interesting to most of us. Crazy and futuristic, yes, but also freeing and fast. But for those with massive spinal cord injuries or degenerative diseases, brain-computer interface technology is an absolute lifeline. In this TechFirst, we…

Read more

Analytics Insight | Exclusive Interview with Marcus Gerhardt, CEO of Blackrock Neurotech

Exclusive Interview with Marcus Gerhardt, CEO of Blackrock Neurotech   With the digital transformation taking over the world, the medical industry is also following in its footsteps. In a small span of time, neurotechnology has advanced a lot and it has been a breakthrough in the health industry. Blackrock Neurotech provides innovative tools and neurotech expertise to…

Read more

Medsider | Why Building a Community is Crucial for Medical Device Startups: Interview with Blackrock Neurotech Co-Founder and CEO Marcus Gerhardt

Why Building a Community is Crucial for Medical Device Startups: Interview with Blackrock Neurotech Co-Founder and CEO Marcus Gerhardt   A common thread runs through Marcus Gerhardt’s career: If a company involves technology and disruption, it’s probably calling his name. Marcus co-founded Blackrock Neurotech in 2008 with his long-time friend and business partner, Florian Solzbacher. Blackrock’s MoveAgain brain-computer interface…

Read more

Health Professional Radio | Blackrock Neurotech – MoveAgain Brain-Computer Interface System

Blackrock Neurotech – MoveAgain Brain-Computer Interface System   Professor Florian Solzbacher, Co-Founder, Chairman, and President of Blackrock Neurotech discusses the MoveAgain Brain-Computer Interface (BCI) System that the FDA has granted a Breakthrough Device designation. It utilizes an array (electrode) implanted in the brain, which decodes intended movement from neuronal activity in the brain. This game-changing portable BCI…

Read more

Neural TNW | BCIs had a big year in the lab. In 2022, they’re coming to the market | The Next Web

BCIs had a big year in the lab. In 2022, they’re coming to the market   Brain-computer interfaces are slowly edging into the mainstream. After a string of scientific breakthroughs, neurotech companies are starting to commercialize their research. Among them is Blackrock Neurotech, which focuses on restoring functions that have been impaired by disabilities or accidents. The company is best-known for…

Read more

Medgadget | Thought-to-Text Brain-Computer Interface: Interview with Florian Solzbacher, Chairman of Blackrock Neurotech

Thought-to-Text Brain-Computer Interface: Interview with Florian Solzbacher, Chairman of Blackrock Neurotech   Blackrock Neurotech, a medical technology company based in Salt Lake City, created a suite of brain-computer interface systems with the goal of empowering patients to have increased independence and quality of life. This latest technology aims to restore written communication in patients who…

Read more